Now available here! PET/CT technology improves assessment of cancer, Alzheimer’s and other diseases

Mike Konsek, nuclear medicine technologist at Winona Health, demonstrates a PET/CT exam.

In March 2018, Winona Health began providing a new diagnostic imaging service that assesses the presence and extent of several diseases, including most types of cancer.

The Computed Tomography/ Positron Emission Tomography (PET/CT) scanner allows physicians to diagnose and determine the extent of various cancers, neurological disorders such as Alzheimer’s disease and epilepsy, and damage to cardiac muscle after a heart attack. Winona Health has partnered with DMS Health Technologies mobile service to bring this technology to Winona.

According to Claudine Van Meeteren, R.T.(R)(M) RDMS, RVT, director of Imaging Services at Winona Health, “Many patients could forego the trauma and cost of unnecessary invasive biopsies and  surgery, and therefore receive earlier and more appropriate therapy, if the extent of their disease had been known beforehand. PET/CT can provide the information to address the possibility of cancer, visualizing the extent and level of malignancy of the disease.”

PET/CT is a medical imaging procedure that provides physicians with information about the body’s chemistry, cell function, and location of disease – information not available through CT, MRI, X-ray, or physical examination. Unlike CT or MRI, which look at anatomy or body structure, PET/CT studies body function or the biology of diseases.

The PET/CT study assists physicians in earlier detection of disease, monitoring the status and response to treatment, and in providing the most appropriate treatment plans.

PET/CT is available to patients by provider referral.

More information about Imaging capabilities at Winona Health is available here.

Print Friendly, PDF & Email